Interaction of central Angiotensin II and estrogen on systolic blood pressure in female DOCA-salt treated rats

Kafami, Marzieh; Hosseini, Mahmoud; Niazmand, Saeed; Hadjzadeh, Mousa Alreza; Farrokhi, Esmaeil; Mazloum, Tahereh; Shafei, Mohammad Naser

Interaction of central Angiotensin II and estrogen on systolic blood pressure in female DOCA-salt treated rats

Authors

¹ Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

² Neurocognetive Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

³ Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad; Neurocognetive Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

⁴ Neurogenic Inflammation Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Background: There is a probable interaction of central angiotensin II (Ang II) and estrogen (Est) on blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Therefore, in the present study, the interaction between Ang II and Est in ovariectomized (Ovx) and Sham rats that were treated with DOCA- salt was evaluated.
Materials and Methods: The female rats were divided into 10 groups as follows: Sham, Ovx, Sham-DOCA, Ovx-DOCA, Sham-DOCA-estrogen (E), Ovx DOCA-E, Sham-DOCA-losartan (L), Ovx-DOCA-L, Sham–DOCA-L-E, and Ovx-DOCA-L-E. The Est groups received estradiol valerate (2 mg/kg; daily; subcutaneously (s.c)) for four weeks. Following that, several doses of Ang II (0.5, 5, 50, 500, 5000 ng/5 μl) were injected via the intracerebroventricular (i.c.v) route and the changes in systolic blood pressure (SBP) were evaluated. In the losartan groups, 200 μg losartan was injected (i.c.v) 15 minutes after the Ang II injection and the blood pressure was recorded. Treatment by DOCA was performed by removal of one kidney, injection of DOCA (45 mg/kg i.p), and adding of sodium chloride (NaCl) (1%) and potassium chloride (KCl) (0.1%) in the drinking water.

Results: The SBP was increased by Ang II and this effect in DOCA-salt treated rat was higher than in the untreated groups. The effect of Ang II on SBP in groups that were treated with Est and L was lower than that in the DOCA-salt groups. Increase in SBP was strongly attenuated by Ang II in groups that were co-treated with both Est and L compared to the DOCA-treated rats. These results showed that Est significantly attenuated the effect of central Ang II on SBP in the DOCA-salt treated rats.
Conclusion: We suggest that there are interactions between E and Ang II in the control of blood pressure in DOCA-salt treated rats.

Keywords

References

1.	Whelton PK. Declining mortality from hypertension and stroke. South Med J 1982;75:33-8. [PUBMED]
2.	Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: Implications for new treatment. Prog Neurobiol 2011;95:89-103.
3.	Skeggs LT, Dorer FE, Kahn JR, Lentz KE, Levine M. The biochemistry of the renin-angiotensin system and its role in hypertension. Am J Med 1976;60:737-48. [PUBMED]
4.	Nguyen Dinh Cat A, Touyz RM. A new look at the renin-angiotensin system--focusing on the vascular system. Peptides 2011;32:2141-50.
5.	Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: Recent advances and perspectives. Br J Pharmacol 2003;139:191-202.
6.	Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, et al. Angiotensin receptors in the nervous system. Brain Res Bull 1998;47:17-28.
7.	Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000;13:31-8S.
8.	McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: The roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol Suppl 1998;25:S61-7.
9.	Casto R, Phillips MI. Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats. Am J Physiol 1986;250:R193-8. [PUBMED]
10.	Becker LK, Santos RA, Campagnole-Santos MJ. Cardiovascular effects of angiotensin II and angiotensin-(1-7) at the RVLM of trained normotensive rats. Brain Res 2005;1040:121-8.
11.	Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol 1986;251:H261-8. [PUBMED]
12.	Ammarguellat F, Larouche I, Schiffrin EL. Myocardial fibrosis in DOCA-salt hypertensive rats: Effect of endothelin ET(A) receptor antagonism. Circulation 2001;103:319-24.
13.	Yu M, Gopalakrishnan V, Robert McNeill JR. Role of endothelin and vasopressin in DOCA-salt hypertension. Br J Pharmacol 2001;132:1447-54.
14.	Xue B, Pamidimukkala J, Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 2005;288:H2177-84.
15.	Shan J, Resnick LM, Liu QY, Wu XC, Barbagallo M, Pang PK. Vascular effects of 17 beta-estradiol in male Sprague-Dawley rats. Am J Physiol 1994;266:H967-73.
16.	Lehrer S, Rabin J, Kalir T, Schachter BS. Estrogen receptor variant and hypertension in women. Hypertension 1993;21:439-41.
17.	Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
18.	Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
19.	Rogers J, Sheriff DD. Role of estrogen in nitric oxide- and prostaglandin-dependent modulation of vascular conductance during treadmill locomotion in rats. J Appl Physiol (1985) 2004;97:756-63.
20.	Morey AK, Pedram A, Razandi M, Prins BA, Hu RM, Biesiada E, et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 1997;138:3330-9.
21.	Hernández I, Delgado JL, Diaz J, Quesada T, Teruel MJ, Llanos MC, et al. 17beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R1599-605.
22.	Shih CD. Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci 2009;16:60.
23.	Wang G, Drake CT, Rozenblit M, Zhou P, Alves SE, Herrick SP, et al. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res 2006;1094:163-78.
24.	Spary EJ, Maqbool A, Batten TF. Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat 2009;38:185-96.
25.	Nematbakhsh M, Khazaei M. The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats. Clin Chim Acta 2004;344:53-7.
26.	Shenoy V, Grobe JL, Qi Y, Ferreira AJ, Fraga-Silva RA, Collamat G, et al. 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 2009;30:2309-15.
27.	David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, et al. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 2001;38:692-6.
28.	Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 2007;292:H1770-6.
29.	Pamidimukkala J, Hay M. 17 beta-Estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol 2003;285:H1515-20.
30.	Hosseini M, Alaei HA, Havakhah S, Neemati Karimooy HA, Gholamnezhad Z. Effects of microinjection of angiotensin II and captopril to VTA on morphine self-administration in rats. Acta Biol Hung 2009;60:241-52.
31.	Hosseini M, Alaei HA, Headari R, Eslamizadeh MJ. Effects of microinjection of angiotensin II and captopril into nucleus accumbens on morphine self-administration in rats. Indian J Exp Biol 2009;47:361-7.
32.	Rahimian R, Laher I, Dube G, van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther 1997;283:116-22.
33.	Stringer JL. Ethosuximide specifically antagonizes the effect of pentylenetetrazol in the rat entorhinal cortex. Epilepsy Res 1996;25:69-77.
34.	Shafei MN, Nasimi A. Effect of glutamate stimulation of the cuneiform nucleus on cardiovascular regulation in anesthetized rats: Role of the pontine Kolliker-Fuse nucleus. Brain Res 2011;1385:135-43.
35.	Nasimi A, Shafei MN, Alaei H. Glutamate injection into the cuneiform nucleus in rat, produces correlated single unit activities in the Kolliker-Fuse nucleus and cardiovascular responses. Neuroscience 2012;223:439-46.
36.	Hosseini M, Sharifi MR, Alaei H, Shafei MN, Karimooy HA. Effects of angiotensin II and captopril on rewarding properties of morphine. Indian J Exp Biol 2007;45:770-7.
37.	Alaei H, Hosseini M. Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats. Pathophysiology 2007;14:55-60.
38.	Rabkin SW. Endogenous kappa opioids mediate the action of brain angiotensin II to increase blood pressure. Neuropeptides 2007;41:411-9.
39.	Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovascular Res 1999;43:985-91.
40.	Ojeda NB, Grigore D, Robertson EB, Alexander BT. Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension 2007;50:679-85.
41.	Ito K, Hirooka Y, Kimura Y, Sagara Y, Sunagawa K. Ovariectomy augments hypertension through rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Hypertension 2006;48:651-7.
42.	Xu X, Xiao JC, Luo LF, Wang S, Zhang JP, Huang JJ, et al. Effects of ovariectomy and 17 beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure. Int J Cardiol 2008;130:196-204.
43.	Ceylan-Isik AF, Erdogan-Tulmac OB, Ari N, Ozansoy G, Ren J. Effect of 17beta-oestradiol replacement on vascular responsiveness in ovariectomized diabetic rats. Clin Exp Pharmacol Physiol 2009;36:e65-71.
44.	Freay AD, Curtis SW, Korach KS, Rubanyi GM. Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta: Role of nuclear estrogen receptor and Ca2+ uptake. Circ Res 1997;81:242-8.
45.	Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved. Hypertension 1998;31:582-8.
46.	Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
47.	Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, et al. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 1997;29:268-73.
48.	Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006;7:335-46.
49.	Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 2003;177:209-18.
50.	Shan Z, Shi P, Cuadra AE, Dong Y, Lamont GJ, Li Q, et al. Involvement of the brain (pro) renin receptor in cardiovascular homeostasis. Circ Res 2010;107:934-8.
51.	Peng JF, Kimura B, Fregly MJ, Phillips MI. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood. Hypertension 1998;31:1317-23.
52.	Chan YS, Wong TM. Relationship of rostral ventrolateral medullary neurons and angiotensin in the central control of blood pressure. Biol Signals 1995;4:133-41.
53.	Kisley LR, Sakai RR, Fluharty SJ. Estrogen decreases hypothalamic angiotensin II AT1 receptor binding and mRNA in the female rat. Brain Res 1999;844:34-42.
54.	Xue B, Zhao Y, Johnson AK, Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 2008;295:H1025-32.
55.	Callera G, Tostes RC, Yogi A, Montezano AC, Touyz RM. Endothelin-1- induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Lond) 2006;110:243-53.
56.	Razmara A, Duckles SP, Krause DN, Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res 2007;1176:71-81.
57.	Schenk J, McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods 1992;27:161-70.
58.	Ouchi Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. J Hypertens 1988;6:381-7.

Advanced Biomedical Research